Generic Marketing Services is a developmental stage company which plans to create and execute sales and marketing programs with the goal of demonstrating Co.'s ability...
Generics should get a large boost in the coming years as branded drugs accounting for more than $38 billion, including Prevacid, Prevachol, Zocor, Zoloft and Paxil, are expected to come off patent by the end of 2008. The paper outlines that the use of generics is definitely on the rise....
Paragraph IV of the Hatch-Waxman Act provides a mechanism for the litigation of pharmaceutical patent infringement disputes. Many of these cases have been settled with "reverse payments" by the brand to the generic in return for delayed generic entry. The FTC has contested a number of these settlements with good...
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/research/c55724/netherlands_pharma) has announced the addition of the "Netherlands Pharmaceuticals and Healthcare Report Q2 2008" report to their offering. The Netherlands Pharmaceuticals and Healthcare Report provides independent forecasts and competitive intelligence on Netherlands pharmaceuticals and healthcare industry. Growth will be far...
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/research/e8deab/snapshots_us_presc) has announced the addition of the "Snapshots US Prescription Pharmaceuticals 2008" report to their offering. Snapdata's Snapshots US Prescription Pharmaceuticals 2008 provides 2007 year-end market size data, with 2008 estimates, 5 years of historical data and five-year forecasts. The Snapshots report...
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/research/0af28c/brazil_pharmaceuti) has announced the addition of the "Brazil Pharmaceuticals and Healthcare Report Q2 2008" report to their offering. The "Brazil Pharmaceuticals and Healthcare Report" provides independent forecasts and competitive intelligence on Brazils pharmaceuticals and healthcare industry. Brazil's pharmaceutical market remains...
-- Federal Court Enters Consent Judgment Terminating Litigation -- HAYWARD, Calif. -- IMPAX Laboratories Inc. today announced that all conditions of a settlement of the U.S. patent infringement litigation pertaining to IMPAX's proposed generic capsule formulation of Wyeth's EFFEXOR XR([R])antidepressant have been approved by the United States District...
AIRLINE INDUSTRY INFORMATION-C1997-2008 M2 COMMUNICATIONS LTD Mechtronix Systems Inc MSI, a provider of flight training equipment, has announced that Turkish Airlines will purchase MSI's Ascent XJ Trainer, an advanced flight trainer. According to MSI, Turkish Airlines plans to use the trainer at its ab-initio school, starting...
NANJING, China, July 15 /PRNewswire-FirstCall/ -- Simcere Pharmaceutical Group , a leading manufacturer and supplier of branded generic pharmaceuticals and innovative anti-cancer pharmaceuticals in the rapidly growing China market, announced today that it intends to release its 2008 second quarter results on Tuesday, August 5, 2008, before the market...
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/research/c7ec8b/venezuela_pharmace) has announced the addition of the "Venezuela Pharmaceuticals and Healthcare Report Q2 2008" report to their offering. The Venezuela Pharmaceuticals and Healthcare Report provides independent forecasts and competitive intelligence on Venezuela's pharmaceuticals and healthcare industry. Prospects in Venezuela's pharmaceutical...
RxElite, Inc. (OTCBB: RXEI) today announcedthe signing of a ten-year development, supply and marketing agreement withHi-Tech Pharmacal Co., Inc., a manufacturer and marketer of liquid genericproducts. Under the terms of the agreement, RxElite will be responsible for theexclusive U.S. supply of active pharmaceutical ingredient to be used in themanufacture of...
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/research/645eb9/italy_pharmaceutic) has announced the addition of the "Italy Pharmaceuticals and Healthcare Report Q2 2008" report to their offering. The Italy Pharmaceuticals and Healthcare Report provides independent forecasts and competitive intelligence on Italy's pharmaceuticals and healthcare industry. Italy's drug market is...
Branded Pharmaceutical companies can expect to see sales drops of up to 70 percent after patent expiration from Generic competition NEW YORK, LONDON and TOKYO, July 14 /PRNewswire/ -- Branded Pharmaceutical companies are painfully aware of the astronomical growth of Generics competition. By the end of this...
:: CHARITY An internationally respected domestic violence charity will mount a legal challenge at the High Court in London on Thursday in an attempt to reverse a funding decision that threatens its future. Southall Black Sisters has worked with black and ethnic minority women victims of violence...
An eight-year Serious Fraud Office SFO investigation that has already cost the taxpayer more than 40m was left hanging in tatters yesterday when a judge at Southwark Crown Court dismissed a case against a number of drugs companies and executives accused of defrauding the NHS. Goldshield, and...
Leading Multiple Sclerosis Therapy Presents Significant Legal and Regulatory Challenges for Generic Filers JERUSALEM -- Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) today commented on Momenta Pharmaceuticals, Inc./Sandoz Inc.'s announcement regarding the filing of a Abbreviated New Drug Application ANDA containing a Paragraph IV certification for COPAXONE[R] glatiramer acetate,...
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/research/a65da8/turkey_pharmaceuti) has announced the addition of the "Turkey Pharmaceuticals and Healthcare Report Q2 2008" report to their offering. The Turkey Pharmaceuticals and Healthcare Report provides independent forecasts and competitive intelligence on Turkeys pharmaceuticals and healthcare industry. The Turkish pharmaceutical market...
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/research/8ed426/selling_your_busin) has announced the addition of the "Selling Your Business Successfully" report to their offering. The report is based on experience and skills by Colin Thompson as a Managing Director of successful organisations. This report/guide is designed as a working reference. It...
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/research/ece90d/china_pharmaceutic) has announced the addition of the "China Pharmaceuticals and Healthcare Report Q2 2008" report to their offering. China's US$34bn pharmaceutical market is the most attractive in BMI's universe, primarily because of its double-digit growth rate. Over the next 12 months, we...
AMITYVILLE, N.Y. -- Hi-Tech Pharmacal Co., Inc. (NASDAQ: HITK) today reported results for the quarter and fiscal year ended April 30, 2008. Fourth Quarter Results For the three months ended April 30, 2008, the Company reported net sales of $21.0 million, an increase of 57% from...
Other Atypicals Thrive by Capturing Specific Patient Populations, According to a New Report from Decision Resources WALTHAM, Mass., July 10 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that Janssen's Risperdal continues to be the...
Articles 2008-07-10
<< Previous
page 1 of 1
Next >>
Premier Vendor Content
Whitepapers, webcasts & resources from our Power Center Sponsors
